Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Dror BashanPresident and CEO | Protalix BioTherapeuticsPLX | Open-market buy | 25/12/19 | 25/12/23 | 56,000 sh | $1.81 | $101,360 | +42.3% |
Amos Bar-ShalevDirector | Protalix BioTherapeuticsPLX | Open-market sale | 25/11/18 | 25/11/19 | 168 sh | $1.87 | $314.16 | −100.0% |
Aharon SchwartzDirector | Protalix BioTherapeuticsPLX | Open-market buy | 25/06/10 | 25/08/12 | 129,000 sh | $1.60 | $206,400 | +74.1% |
Protalix BioTherapeuticsPLX | Open-market buy | 23/10/19 | 23/10/20 | 64,516 sh2 trades | $1.40avg. | $90,483.69 | +94.9% | |
Aharon SchwartzDirector | Protalix BioTherapeuticsPLX | Open-market buy | 23/01/03 | 23/01/05 | 110,000 sh | $1.42 | $156,200 | +171.9% |